Company News Cytena GmbH announces that it has been entered into an agreement to be acquired by CELLINK August 5, 2019 Freiburg, Germany – August 5, 2019 – The owners of Cytena GmbH (“Cytena”) have agreed to sell all Cytena shares to CELLINK AB (“CELLINK”) for a purchase price of 30.25M […] Freiburg, Germany – August 5, 2019 – The owners of Cytena GmbH (“Cytena”) have agreed to sell all Cytena shares to CELLINK AB (“CELLINK”) for a purchase price of 30.25M […]
Company News Cytena founds subsidiary in Taiwan July 23, 2019 Freiburg, Germany – July 23, 2019 – Cytena, the specialist for single-cell technologies, is continuing its growth with the establishment of its subsidiary Cytena Bioprocess Solutions in Taiwan. Cytena […]
Company News Success in the project “Mono-cy-clone“ April 29, 2019 The “Mono-cy-clone” project was funded by the Federal Ministry of Education and Research with 1.5 million euros as part of the “KMU-innovativ: Biotechnologie-BioChance” programme from […]
Company News EUR 3 million in series A for the growth and development of Cytena GmbH March 26, 2019 Two private investors and High-Tech Gründerfonds (HTGF) are convinced of the importance of single-cell isolation for the production of biopharmaceuticals and for genetic analysis in […]
Company News Our long-time customer Genentech in San Francisco about our single-cell printer: “Leading instrument and great results” July 5, 2018
Company News Cytena receives the Innovation Award of the Federal State of Baden-Württemberg – Dr. Rudolf-Eberle-Prize 2017 November 29, 2017